Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates
- 31 July 2005
- journal article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 52 (3), 209-213
- https://doi.org/10.1016/j.diagmicrobio.2005.06.010
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002Diagnostic Microbiology and Infectious Disease, 2005
- Tigecycline: clinical evidence and formulary positioningInternational Journal of Antimicrobial Agents, 2005
- AcrAB Efflux Pump Plays a Role in Decreased Susceptibility to Tigecycline in Morganella morganiiAntimicrobial Agents and Chemotherapy, 2005
- In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infectionsDiagnostic Microbiology and Infectious Disease, 2004
- Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNAJournal of Antimicrobial Chemotherapy, 2004
- The GlycylcyclinesDrugs, 2004
- In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesJournal of Antimicrobial Chemotherapy, 2003
- Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2003
- In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamasesDiagnostic Microbiology and Infectious Disease, 2001
- Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial ResistanceMicrobiology and Molecular Biology Reviews, 2001